| Literature DB >> 31652870 |
Yukimasa Matsuzawa1, Kiyoko Iwatsuki-Horimoto2, Yoshinori Nishimoto3, Yukiko Abe4, Satoshi Fukuyama5, Taiki Hamabata6, Moe Okuda7, Yui Go8, Tokiko Watanabe9, Masaki Imai10, Yasumichi Arai11, Ron A M Fouchier12, Seiya Yamayoshi13, Yoshihiro Kawaoka14,15,16.
Abstract
Human influenza A(H2N2) viruses emerged in 1957 and were replaced by A(H3N2) viruses in 1968. The antigenicity of human H2N2 viruses has been tested by using ferret antisera or mouse and human monoclonal antibodies. Here, we examined the antigenicity of human H2N2 viruses by using human plasma samples obtained from 50 aged individuals who were born between 1928 and 1933 and from 33 younger adult individuals who were born after 1962. The aged individuals possessed higher neutralization titers against H2N2 viruses isolated in 1957 and 1963 than those against H2N2 viruses isolated in 1968, whereas the younger adults who were born between 1962 and 1968 possessed higher neutralization titers against H2N2 viruses isolated in 1963 than those against other H2N2 viruses. Antigenic cartography revealed the antigenic changes that occurred in human H2N2 viruses during circulation in humans for 11 years, as detected by ferret antisera. These results show that even though aged individuals were likely exposed to more recent H2N2 viruses that are antigenically distinct from the earlier H2N2 viruses, they did not possess high neutralizing antibody titers to the more recent viruses, suggesting immunological imprinting of these individuals with the first H2N2 viruses they encountered and that this immunological imprinting lasts for over 50 years.Entities:
Keywords: H2N2; aged individuals; antigenic change; antigenic drift; influenza A virus
Year: 2019 PMID: 31652870 PMCID: PMC6893718 DOI: 10.3390/v11110978
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Characteristics of the participants in this study.
| No. of Individuals | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Birth Year | |||||||||||
| Aged Individuals | Younger Adult Individuals | ||||||||||
| 1928 | 1929 | 1930 | 1931 | 1932 | 1933 | 1960s | 1970s | 1980s | 1990s | ||
| Males | 4 | 4 | 4 | 4 | 4 | 4 | 10 | 5 | 1 | 2 | |
| Females | 5 | 5 | 4 | 4 | 4 | 4 | 9 | 3 | 2 | 1 | |
| Total | 9 | 9 | 8 | 8 | 8 | 8 | 19 | 8 | 3 | 3 | |
| Medical history b | Heart disease | 3/9 | 1/9 | 3/8 | 1/8 | 1/8 | 1/8 | NA a | NA | NA | NA |
| Diabetes | 0/9 | 0/9 | 1/8 | 2/8 | 1/8 | 1/8 | NA | NA | NA | NA | |
| Cancer | 3/9 | 2/9 | 2/8 | 4/8 | 2/8 | 2/8 | NA | NA | NA | NA | |
a Not available. b Summary of available medical history of each individual.
Neutralization titers of aged and younger adult individuals.
| ID | Birth Year (age) | M1/57 a | K1/63 b | B1/68 c | B2/68 d |
|---|---|---|---|---|---|
| 1 | 1928 (89) | 128 | 8 | 8 | 8 |
| 2 | 1928 (89) | 8 | 32 | 4 | 16 |
| 3 | 1928 (89) | 64 | 32 | <4 | 16 |
| 4 | 1928 (89) | 32 | 32 | 4 | 8 |
| 5 | 1928 (89) | 256 | 128 | 32 | 8 |
| 6 | 1928 (89) | 64 | 32 | <4 | 16 |
| 7 | 1928 (89) | 256 | 32 | 16 | 16 |
| 8 | 1928 (89) | 128 | 64 | 4 | 32 |
| 9 | 1928 (89) | 8 | 16 | <4 | <4 |
| 10 | 1929 (89) | 64 | 32 | 8 | 16 |
| 11 | 1929 (89) | 8 | 32 | <4 | <4 |
| 12 | 1929 (89) | 128 | 64 | 4 | 8 |
| 13 | 1929 (89) | 8 | 32 | <4 | 8 |
| 14 | 1929 (89) | 256 | 64 | 4 | 4 |
| 15 | 1929 (89) | 32 | 8 | <4 | 4 |
| 16 | 1929 (89) | 32 | 32 | 4 | <4 |
| 17 | 1929 (88) | 32 | 64 | 8 | 8 |
| 18 | 1929 (88) | 32 | 128 | 4 | 16 |
| 19 | 1930 (88) | 16 | 16 | <4 | 8 |
| 20 | 1930 (88) | 16 | 8 | 4 | 4 |
| 21 | 1930 (88) | 32 | 64 | <4 | 8 |
| 22 | 1930 (88) | 256 | 64 | 8 | 4 |
| 23 | 1930 (87) | 64 | 64 | 4 | 16 |
| 24 | 1930 (87) | 128 | 32 | 4 | 32 |
| 25 | 1930 (87) | 256 | 16 | 4 | 16 |
| 26 | 1930 (87) | 256 | 64 | 8 | 8 |
| 27 | 1931 (87) | 128 | 64 | 4 | 32 |
| 28 | 1931 (87) | 16 | 16 | <4 | <4 |
| 29 | 1931 (87) | 16 | 64 | 8 | 16 |
| 30 | 1931 (87) | 32 | 16 | 4 | 16 |
| 31 | 1931 (86) | 32 | 16 | <4 | <4 |
| 32 | 1931 (86) | 32 | 4 | <4 | 4 |
| 33 | 1931 (86) | 32 | 32 | <4 | 4 |
| 34 | 1931 (86) | 128 | 32 | 4 | 8 |
| 35 | 1932 (86) | 256 | 32 | 8 | 4 |
| 36 | 1932 (86) | 32 | 32 | <4 | 32 |
| 37 | 1932 (86) | 256 | 32 | 8 | 4 |
| 38 | 1932 (86) | 16 | 8 | <4 | 8 |
| 39 | 1932 (86) | 256 | 128 | <4 | 8 |
| 40 | 1932 (85) | 256 | 32 | 8 | 16 |
| 41 | 1932 (85) | 32 | 32 | <4 | 4 |
| 42 | 1932 (85) | 64 | 64 | 4 | 4 |
| 43 | 1933 (85) | 16 | 16 | 8 | 16 |
| 44 | 1933 (85) | 256 | 64 | 8 | 8 |
| 45 | 1933 (85) | 256 | 32 | 4 | <4 |
| 46 | 1933 (85) | 32 | 16 | 4 | 4 |
| 47 | 1933 (85) | 128 | 64 | 8 | 16 |
| 48 | 1933 (85) | >512 | 128 | 64 | 64 |
| 49 | 1933 (85) | 64 | 64 | 8 | 16 |
| 50 | 1933 (85) | 8 | 128 | 4 | 4 |
| 51 | 1962 (56) | 4 | 64 | 8 | 128 |
| 52 | 1962 (55) | <4 | 16 | 4 | 4 |
| 53 | 1962 (55) | 8 | 32 | 16 | 32 |
| 54 | 1962 (55) | 16 | 32 | 8 | 8 |
| 55 | 1963 (55) | 32 | >512 | 32 | 64 |
| 56 | 1963 (55) | 32 | >512 | 64 | 256 |
| 57 | 1963 (55) | 8 | 128 | 64 | 64 |
| 58 | 1963 (55) | 16 | 256 | 16 | 32 |
| 59 | 1964 (54) | 8 | 128 | 8 | 32 |
| 60 | 1965 (53) | 4 | 64 | 4 | 32 |
| 61 | 1966 (52) | 8 | 32 | 8 | 32 |
| 62 | 1966 (51) | 8 | 128 | 16 | 64 |
| 63 | 1967 (51) | 4 | 64 | 16 | 16 |
| 64 | 1967 (50) | <4 | 32 | 4 | 8 |
| 65 | 1968 (50) | <4 | 4 | <4 | <4 |
| 66 | 1968 (49) | 4 | 16 | 4 | 8 |
| 67 | 1969 (49) | 4 | 32 | 8 | 32 |
| 68 | 1969 (49) | <4 | <4 | <4 | <4 |
| 69 | 1969 (48) | 4 | 16 | 4 | 16 |
| 70 | 1970 (48) | 8 | 4 | 8 | 16 |
| 71 | 1970 (47) | <4 | 8 | 4 | 32 |
| 72 | 1970 (47) | <4 | 8 | <4 | 16 |
| 73 | 1970 (47) | <4 | 16 | 8 | 4 |
| 74 | 1970 (47) | <4 | 4 | <4 | 8 |
| 75 | 1972 (45) | <4 | <4 | <4 | <4 |
| 76 | 1974 (44) | <4 | <4 | <4 | 4 |
| 77 | 1978 (39) | <4 | <4 | <4 | <4 |
| 78 | 1980 (37) | <4 | <4 | <4 | <4 |
| 79 | 1982 (36) | <4 | <4 | <4 | <4 |
| 80 | 1985 (33) | <4 | <4 | <4 | <4 |
| 81 | 1990 (27) | <4 | <4 | <4 | <4 |
| 82 | 1992 (26) | <4 | <4 | <4 | 4 |
| 83 | 1994 (23) | <4 | <4 | <4 | 4 |
Neutralization titers of plasma samples of aged individuals (ID 1–50) and younger adult individuals (ID 51–83) against A/Netherland/M1/57 a, A/Netherland/K1/63 b, A/Netherland/B1/68 c, or A/Netherland/B2/68 d were measured.
Figure 1Phylogenetic tree based on the amino acid sequences of HA1 derived from human H2N2 viruses. This tree was constructed by using the Maximum Likelihood method and JTT matrix-based model. Virus isolates used for antigenic analysis are highlighted in magenta.
Figure 2Neutralization titers of aged individuals (A) and younger adult individuals (B) against human H2N2 viruses. The neutralization titers against the viruses indicated in Table 2 were plotted. A non-parametric Friedman’s test followed by a two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli was performed. * and *** mean p < 0.05 and p < 0.0001, respectively. (C) Bubble chart of the neutralization titers of all of the individuals. The bigger the circle, the higher the neutralization titer.
Figure 3An antigenic map of human H2N2 viruses. An antigenic map was generated from the neutralization data shown in Table 2. Viruses are represented as circles and plasma samples obtained from aged or younger adults are represented as black or grey squares, respectively. Sera with no or only 1 numerical antibody titer are not shown as they cannot be placed properly in an antigenic map. The grid indicates one unit of antigenic distance, a two-fold dilution in neutralization titer.
Comparison of amino acids that are important for HA antigenicity a.
| Isolate | Amino Acid Position at | ||||||
|---|---|---|---|---|---|---|---|
| 126 | 128 | 132 | 139 | 154 | 184 | 188 | |
| A/Netherland/M1/57 | T | T | R | N | S | T | T |
| A/Netherland/K1/63 | T | T | R | N | P | A | A |
| A/Netherland/B1/68 | E | D | K | K | P | A | A |
| A/Netherland/B2/68 | K | D | K | K | Q | E | A |
a Amino acids that are different among the HAs of the four isolates at previously identified antigenic determinants [11] are listed.